Matthew K Szot insider trades: Cadrenal Therapeutics (CVKD) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Matthew reports to the SEC
and 2 more companies
Open-market buys and sales
32 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 29, 2025 | CVKD | ↓ Sell10b5-1 | 9,933 | $6.97 | $69K | Direct | Dec 31, 2025 (2d) |
| Dec 3, 2025 | IVF | ↓ Sell | 4 | $1.52 | $6 | Direct | Dec 5, 2025 (2d) |
| Nov 14, 2025 | SNES | ↓ Sell | 1 | $2.75 | $3 | Direct | Nov 17, 2025 (3d) |
| Oct 27, 2025 | CVKD | ↓ Sell10b5-1 | 3,600 | $13.99 | $50K | Direct | Oct 28, 2025 (1d) |
| Oct 13, 2025 | CVKD | ↓ Sell10b5-1 | 3,493 | $14.03 | $49K | Direct | Oct 14, 2025 (1d) |
| Oct 6, 2025 | CVKD | ↓ Sell10b5-1 | 107 | $13.99 | $1K | Direct | Oct 7, 2025 (1d) |
| Oct 1, 2025 | CVKD | ↓ Sell10b5-1 | 1,800 | $13.99 | $25K | Direct | Oct 1, 2025 (0d) |
| Sep 25, 2025 | CVKD | ↓ Sell | 12,400 | $14.05 | $174K | Direct | Sep 26, 2025 (1d) |
| Aug 28, 2025 | CVKD | ↓ Sell | 2,000 | $14.00 | $28K | Direct | Aug 29, 2025 (1d) |
| Jun 1, 2022 | INVO | ↑ Buy | 14,474 | $0.95 | $14K | Direct | Jun 3, 2022 (2d) |
| May 20, 2020 | SANW | ↑ Buy | 1,000 | $2.04 | $2K | Direct | May 20, 2020 (0d) |
| Mar 18, 2020 | SANW | ↑ Buy | 2,000 | $1.80 | $4K | Direct | Mar 18, 2020 (0d) |
| Jan 2, 2019 | SANW | ↓ Sell | 1,100 | $1.84 | $2K | Direct | Jan 3, 2019 (1d) |
| Oct 1, 2018 | SANW | ↓ Sell | 1,100 | $2.46 | $3K | Direct | Oct 3, 2018 (2d) |
| Jul 2, 2018 | SANW | ↓ Sell | 1,100 | $3.15 | $3K | Direct | Jul 3, 2018 (1d) |
| Apr 2, 2018 | SANW | ↓ Sell | 1,100 | $3.50 | $4K | Direct | Apr 3, 2018 (1d) |
| Jan 16, 2018 | SANW | ↓ Sell | 1,100 | $4.00 | $4K | Direct | Jan 16, 2018 (0d) |
| Oct 2, 2017 | SANW | ↓ Sell | 1,100 | $3.10 | $3K | Direct | Oct 3, 2017 (1d) |
| Jul 3, 2017 | SANW | ↓ Sell | 1,100 | $4.05 | $4K | Direct | Jul 5, 2017 (2d) |
| Apr 3, 2017 | SANW | ↓ Sell | 1,100 | $4.97 | $5K | Direct | Apr 4, 2017 (1d) |
| Jan 11, 2017 | SANW | ↓ Sell | 1,100 | $4.75 | $5K | Direct | Jan 11, 2017 (0d) |
| Oct 3, 2016 | SANW | ↓ Sell | 51,100 | $5.10 | $261K | Direct | Oct 4, 2016 (1d) |
| Jul 1, 2016 | SANW | ↓ Sell | 1,100 | $4.31 | $5K | Direct | Jul 6, 2016 (5d) |
| Apr 1, 2016 | SANW | ↓ Sell | 1,100 | $4.18 | $5K | Direct | Apr 5, 2016 (4d) |
| Jan 4, 2016 | SANW | ↓ Sell | 1,100 | $4.20 | $5K | Direct | Jan 5, 2016 (1d) |
| Oct 1, 2015 | SANW | ↓ Sell | 1,100 | $4.59 | $5K | Direct | Oct 5, 2015 (4d) |
| Jul 1, 2015 | SANW | ↓ Sell | 1,100 | $4.82 | $5K | Direct | Jul 6, 2015 (5d) |
| Apr 1, 2015 | SANW | ↓ Sell | 1,100 | $4.66 | $5K | Direct | Apr 3, 2015 (2d) |
| Feb 17, 2015 | SANW | ↓ Sell10b5-1 | 25,000 | $4.74 | $118K | Direct | Feb 19, 2015 (2d) |
| Jan 2, 2015 | SANW | ↓ Sell | 1,100 | $3.90 | $4K | Direct | Jan 5, 2015 (3d) |
| Oct 1, 2014 | SANW | ↓ Sell | 1,100 | $4.12 | $5K | Direct | Oct 3, 2014 (2d) |
| Jan 22, 2009 | QTUM | ↑ Buy | 15,000 | $0.00 | $15 | Direct | Jan 30, 2009 (8d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CVKD insiders
Open-market trades in the last 12 months
About Matthew K Szot's insider trades
Matthew K Szot is Chief Financial Officer at Cadrenal Therapeutics (CVKD). Since Jan 22, 2009, Matthew has reported 4 open-market purchases worth $19K and 28 sales worth $850K on SEC Form 4. In the last 12 months: 3 sales ($69K).
6 sales (37% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (42 filings), shares withheld for taxes (37 filings), grants and awards (35 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CVKD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.